NewEdge Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.34M Buy
24,427
+3,772
+18% +$825K 0.03% 546
2025
Q1
$4.62M Buy
20,655
+3,554
+21% +$796K 0.03% 530
2024
Q4
$5.6M Buy
17,101
+1,145
+7% +$375K 0.03% 461
2024
Q3
$4.79M Buy
15,956
+13,503
+550% +$4.05M 0.03% 490
2024
Q2
$808K Buy
2,453
+114
+5% +$37.6K 0.01% 1166
2024
Q1
$926K Sell
2,339
-4,585
-66% -$1.81M 0.01% 1041
2023
Q4
$2.44M Sell
6,924
-455
-6% -$160K 0.02% 598
2023
Q3
$2.77M Buy
7,379
+2,636
+56% +$989K 0.03% 484
2023
Q2
$1.81M Buy
4,743
+3,688
+350% +$1.41M 0.02% 622
2023
Q1
$379K Buy
1,055
+154
+17% +$55.3K ﹤0.01% 1245
2022
Q4
$45.6K Sell
901
-5,621
-86% -$284K ﹤0.01% 1756
2022
Q3
$1.61M Buy
6,522
+770
+13% +$189K 0.03% 484
2022
Q2
$1.74M Buy
+5,752
New +$1.74M 0.03% 475
2022
Q1
Sell
-10,033
Closed -$4.71M 1661
2021
Q4
$4.71M Buy
10,033
+3,746
+60% +$1.76M 0.07% 257
2021
Q3
$2.67M Buy
6,287
+195
+3% +$82.8K 0.07% 265
2021
Q2
$2.19M Buy
6,092
+502
+9% +$180K 0.06% 285
2021
Q1
$1.58M Sell
5,590
-328
-6% -$92.4K 0.05% 336
2020
Q4
$1.68M Buy
5,918
+375
+7% +$106K 0.06% 291
2020
Q3
$1.52M Buy
5,543
+2,388
+76% +$657K 0.05% 292
2020
Q2
$717K Sell
3,155
-222
-7% -$50.5K 0.03% 445
2020
Q1
$514K Buy
3,377
+849
+34% +$129K 0.02% 442
2019
Q4
$380K Sell
2,528
-92
-4% -$13.8K 0.02% 600
2019
Q3
$372K Buy
2,620
+64
+3% +$9.09K 0.02% 582
2019
Q2
$320K Buy
2,556
+10
+0.4% +$1.25K 0.02% 511
2019
Q1
$281K Buy
2,546
+241
+10% +$26.6K 0.02% 544
2018
Q4
$226 Buy
2,305
+52
+2% +$5 0.01% 564
2018
Q3
$278K Buy
+2,253
New +$278K 0.02% 517
2017
Q3
Sell
-175
Closed -$16.3K 1133
2017
Q2
$16.3K Buy
+175
New +$16.3K ﹤0.01% 799